Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer

Cited by (1,001)

Items 401–500 of 1,001

1. Using Organotypic Tissue Slices to Investigate the Microenvironment of Pancreatic Cancer: Pharmacotyping and Beyond
   Jonathan Weitz, Hervé Tiriac, Tatiana Hurtado de Mendoza, Alexis A. Wascher, Andrew M. Lowy · 2021 · Cancers
2. Application of immune enhanced organoids in modeling personalized Merkel cell carcinoma research
   Steven Donald Forsythe, Richard A. Erali, Preston Laney, Hemamylammal Sivakumar, Wencheng Li, Aleksander Skardal, Shay Söker, Konstantinos Ioannis Votanopoulos · 2022 · Scientific Reports
3. Genomic and Epigenomic Characterization of Tumor Organoid Models
   Chehyun Nam, Benjamin Ziman, Megha Sheth, Hua Zhao, De‐Chen Lin · 2022 · Cancers
4. Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction
   Kazuhide Matsumoto, Nao Fujimori, Kazuya Ichihara, Ayumu Takeno, Masatoshi Murakami, Akihisa Ohno, Shotaro Kakehashi, Katsuhito Teramatsu, Keijiro Ueda, Kohei Nakata et al. · 2024 · Journal of Gastroenterology
5. Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles
   Hassan A. Ali, Joanna M. Karasinska, James Thomas Topham, Danisha Johal, Steve E. Kalloger, Andrew Metcalfe, Cassia Warren, A. Miyagi, Lan Valerie Tao, Maya Kevorkova et al. · 2024 · Cancer & Metabolism
6. The biological macromolecules constructed Matrigel for cultured organoids in biomedical and tissue engineering
   Ke-yu Zhao, Yu Du, Huimin Cao, Liya Su, Xiulan Su, Xian Li · 2024 · Colloids and Surfaces B Biointerfaces
7. Advancing pancreatic cancer research and therapeutics: the transformative role of organoid technology
   Jihao Xu, Minh Duc Pham, Vincenzo Corbo, Mariano Ponz‐Sarvisé, Tobiloba E. Oni, Daniel Öhlund, Chang‐Il Hwang · 2025 · Experimental & Molecular Medicine
8. Nuclear Dynamics and Chromatin Structure: Implications for Pancreatic Cancer
   Luis F. Flores, Brooke R Tader, Ezequiel J. Tolosa, Ashley N. Sigafoos, David L. Marks, Martín E. Fernández-Zapico · 2021 · Cells
9. Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer
   Sadanori Watanabe, Akitada Yogo, Tsuguteru Otsubo, Hiroki Umehara, Jun Oishi, Toru Kodo, Toshihiko Masui, Shigeo Takaishi, Hiroshi Seno, Shinji Üemoto et al. · 2022 · BMC Cancer
10. Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments
    Marzia Conte, Valentina Cauda · 2022 · Advanced Therapeutics
11. Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors
    Marlies C. Ludikhuize, Sira Gevers, Nguyen BT Nguyen, Maaike Meerlo, S. Khadijeh Shafiei Roudbari, M. Can Gülersönmez, Edwin C.A. Stigter, Jarno Drost, Hans C. Clevers, Boudewijn M.T. Burgering et al. · 2022 · Communications Biology
12. Exploring New Dimensions of Tumor Heterogeneity: The Application of Single Cell Analysis to Organoid‐Based 3D In Vitro Models
    Natalie Landon‐Brace, Nancy T. Li, Alison P. McGuigan · 2023 · Advanced Healthcare Materials
13. Colorectal carcinoma peritoneal metastases-derived organoids: results and perspective of a model for tailoring hyperthermic intraperitoneal chemotherapy from bench-to-bedside
    Luca Varinelli, Davide Battistessa, Marcello Guagliò, Susanna Zanutto, Oscar Illescas, Ewelina Lorenc, Federica Pisati, Shigeki Kusamura M. D, Laura Cattaneo, Giovanna Sabella et al. · 2024 · Journal of Experimental & Clinical Cancer Research
14. Cholangiocarcinoma Disease Modelling Through Patients Derived Organoids
    Francesco Amato, Colin J. Rae, Maria Giuseppina Prete, Chiara Braconi · 2020 · Cells
15. An Engineered Patient‐Derived Tumor Organoid Model That Can Be Disassembled to Study Cellular Responses in a Graded 3D Microenvironment
    Natalie Landon‐Brace, Jose L. Cadavid, Simon Latour, Ileana L. Co, Darren Rodenhizer, Nancy T. Li, Nila C. Wu, Eryn Bugbee, Aleks Chebotarev, Ji Zhang et al. · 2021 · Advanced Functional Materials
16. A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis Induction
    Carolin Schneider, Jorina Hilbert, Franziska Génevaux, Stefanie Höfer, Lukas Krauß, Felix Schicktanz, Constanza Tapia Contreras, Shaishavi Jansari, Aristeidis Papargyriou, Thorsten Richter et al. · 2024 · Advanced Science
17. Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer
    Jonathan M. DeLiberty, Mallory K. Roach, Clint A. Stalnecker, Ryan N. Robb, Elyse G. Schechter, Noah L. Pieper, Khalilah E. Taylor, Lily M. Pita, Runying Y. Yang, Scott Bang et al. · 2025 · Cancer Research
18. Drivers of Gene Expression Dysregulation in Pancreatic Cancer
    Swati Venkat, Abdulrahman A. Alahmari, Michael E. Feigin · 2021 · Trends in cancer
19. Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma
    Andrew Armstrong, Muhammad R. Haque, Sina Mirbagheri, Usman Barlass, Douglas Z. Gilbert, Jaimin P. Amin, Ajaypal Singh, Ankur D Naqib, Faraz Bishehsari · 2021 · Biomedicines
20. Targeting the Stroma in the Management of Pancreatic Cancer
    Penelope Edwards, Byung Woog Kang, Ian Chau · 2021 · Frontiers in Oncology
21. Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?
    Evangelia Sereti, Irida Papapostolou, KONSTANTINOS S. DIMAS · 2023 · Biomedicines
22. Antitumor effect of luteolin proven by patient‐derived organoids of gastric cancer
    Xinyu Hao, Ming Zu, Jing Ning, Xin Zhou, Yueqing Gong, Xiurui Han, Qiao Meng, Dong Li, Shigang Ding · 2023 · Phytotherapy Research
23. Paired organoids from primary gastric cancer and lymphatic metastasis are useful for personalized medicine
    Ruixin Yang, Qi Yao, Wingyan Kwan, Yutong Du, Ranlin Yan, Lu Zang, Xuexin Yao, Chen Li, Zhenggang Zhu, Xiaoyan Zhang et al. · 2024 · Journal of Translational Medicine
24. Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC
    Katharina Lankes, Zonera Hassan, Josefina Doffo, Christian Schneeweis, Svenja Lier, Rupert Öllinger, Roland Rad, Oliver Holger Krämer, Ulrich Bernd Keller, Dieter Saur et al. · 2020 · Molecular Oncology
25. From cell lines to living biosensors: new opportunities to prioritize cancer dependencies using ex vivo tumor cultures
    Yuen‐Yi Tseng, Jesse S. Boehm · 2019 · Current Opinion in Genetics & Development
26. Current status and perspectives of patient-derived rare cancer models
    Tadashi Kondo · 2020 · Human Cell
27. Organoids for the Study of Liver Cancer
    Haichuan Wang, Diego Francesco Calvisi, Xin Chen · 2021 · Seminars in Liver Disease
28. DNA Damage Repair Deficiency in Pancreatic Ductal Adenocarcinoma: Preclinical Models and Clinical Perspectives
    Jojanneke Stoof, Emily C. Harrold, Sarah Mariottino, Maeve Aine Lowery, Naomi Walsh · 2021 · Frontiers in Cell and Developmental Biology
29. Animal models for modeling pancreatic cancer and novel drug discovery
    Savita Bisht, Georg Feldmann · 2019 · Expert Opinion on Drug Discovery
30. ATM-Mutated Pancreatic Cancer
    Candice Martino, Deep S. Pandya, Ronald Demos Lee, Gillian H. Levy, Tammy Lo, Sandra Lobo, Richard C. Frank · 2019 · Pancreas
31. Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions
    Steven Donald Forsythe, Tracey Pu, Stephen G. Andrews, James P. Madigan, Samira Mercedes Sadowski · 2023 · Cancers
32. Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity
    Maikel Verduin, Linde Hoosemans, Maxime Vanmechelen, Mike van Heumen, Jolanda A. F. Piepers, Galuh Astuti, Linda P.C.M. Ackermans, Olaf E. M. G. Schijns, Kim Rosalie Kampen, Vivianne C. G. Tjan‐Heijnen et al. · 2023 · Neuro-Oncology Advances
33. KRAS-Driven Tumorigenesis and KRAS-Driven Therapy in Pancreatic Adenocarcinoma
    Minh T. Than, Mark H. O’Hara, Ben Z. Stanger, Kim A. Reiss · 2024 · Molecular Cancer Therapeutics
34. Developing Patient-Derived 3D-Bioprinting models of pancreatic cancer
    Hang Sun, Yan Wang, Minghao Sun, Xindi Ke, Changcan Li, Bao Jin, Mingchang Pang, Yanan Wang, Shangze Jiang, Liwei Du et al. · 2024 · Journal of Advanced Research
35. Organoid‐based precision medicine in pancreatic cancer
    Alica K. Beutel, Menar Ekizce, Thomas Jens Ettrich, Thomas Theodor Werner Seufferlein, Jessica Lindenmayer, Johann Gout, Alexander Kleger · 2024 · United European Gastroenterology Journal
36. Combination therapies induce cancer cell death through the integrated stress response and disturbed pyrimidine metabolism
    Goetz Hartleben, Kenji Schorpp, Yun Kwon, Barbara Betz, Foivos‐Filippos Tsokanos, Zahra Dantes, Arlett Schäfer, Ina Rothenaigner, José Manuel Monroy Kuhn, Pauline Morigny et al. · 2021 · EMBO Molecular Medicine
37. Palbociclib-based high-throughput combination drug screening identifies synergistic therapeutic options in HPV-negative head and neck squamous cell carcinoma
    Ziyue Gu, Chaoji Shi, Jiayi Li, Yong Han, Bao Sun, Wuchang Zhang, Jing Wu, Guoyu Zhou, Weimin Ye, Jiang Li et al. · 2022 · BMC Medicine
38. Christmas Tree-Shaped Microneedles as FOLFIRINOX Spatiotemporal Delivery System for Pancreatic Cancer Treatment
    Danqing Huang, Xiao Fu, Xiaoxuan Zhang, Yuanjin Zhao · 2022 · Research
39. The tumor microenvironment and immune targeting therapy in pediatric renal tumors
    Amy B Hont, Benoît Dumont, Kathryn S. Sutton, John Anderson, Alex Kentsis, Jarno Drost, Andrew Lee Hong, Arnauld C. Verschuur · 2022 · Pediatric Blood & Cancer
40. Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators
    Saptarshi Mallick, Jayati L. Chakrabarti, Jennifer Mary Eschbacher, Andreas G. Moraitis, Andrew E. Greenstein, Jared M. Churko, Kelvin W. Pond, Antonia Livolsi, Curtis A. Thorne, Andrew S. Little et al. · 2023 · Translational research
41. Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk
    Hongquan Qin, Jiali Chen, Katia Bouchekioua‐Bouzaghou, Ya-Ming Meng, Jordi Bach, Xue Jiang, Xiangzhan Kong, Minghui Wang, Qiuping Xu, Ping‐Pui Wong · 2023 · Journal of Translational Medicine
42. Wnt-deficient and hypoxic environment orchestrates squamous reprogramming of human pancreatic ductal adenocarcinoma
    Hiroki Tamagawa, Masayuki Fujii, Kazuhiro Togasaki, Takashi Seino, Shintaro Kawasaki, Ai Takano, Kohta Toshimitsu, Sirirat Takahashi, Yuki Ohta, Mami Matano et al. · 2024 · Nature Cell Biology
43. Application of single-cell sequencing technologies in pancreatic cancer
    Mastan Mannarapu, Begum Dariya, Obul Reddy Bandapalli · 2021 · Molecular and Cellular Biochemistry
44. In vitro drug testing using patient-derived ovarian cancer organoids
    Lin‐Yu Chen, Yu-Ting Chou, Phui‐Ly Liew, Ling-Hui Chu, Kuo‐Chang Wen, Shiou‐Fu Lin, Yu‐Chun Weng, Hui-Chen Wang, Po‐Hsuan Su, Hung‐Cheng Lai · 2024 · Journal of Ovarian Research
45. Bridging the gap: the role of 3D cell cultures in mimicking tumor microenvironment for enhanced drug testing accuracy
    Yan Zhou, Fei‐Yuan Yu, Min Guo, Yao Tang, Qian Xu · 2025 · Frontiers in Bioengineering and Biotechnology
46. Emerging insights into lineage plasticity in pancreatic cancer initiation, progression, and therapy resistance
    Xintong Zhang, Yaru Du, Axel Behrens, Linxiang Lan · 2025 · Developmental Cell
47. A pancreas tumor derived organoid study: from drug screen to precision medicine
    Jia Yao, Man Yang, Lawrence Lawer Atteh, Pinyan Liu, Yongcui Mao, Wenbo Meng, Xun Li · 2021 · Cancer Cell International
48. Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response
    Geny Piro, Antonio Agostini, Alberto Larghi, Giuseppe Quero, Carmine Carbone, Annachiara Esposito, Gianenrico Rizzatti, Fabia Attili, Sergio Alfieri, Guido Costamagna et al. · 2021 · Frontiers in Medicine
49. Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient Management
    Daniel Schreyer, John P. Neoptolemos, Simon T. Barry, Peter Bailey · 2022 · Frontiers in Cell and Developmental Biology
50. Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring
    Lotta Mäkinen, Markus J. V. Vähä-Koskela, Matilda Juusola, Harri K. Mustonen, Krister Wennerberg, Jaana Hagström, Pauli Antero Puolakkainen, Hanna E. Seppänen · 2022 · Cancers
51. An off-the-shelf multi-well scaffold-supported platform for tumour organoid-based tissues
    Nancy T. Li, Nila C. Wu, Ruonan Cao, Jose L. Cadavid, Simon Latour, Xiaoya Lu, Yutong Zhu, Mirjana Mijalkovic, Reza Roozitalab, Natalie Landon‐Brace et al. · 2022 · Biomaterials
52. Pancreatic Organoids: A Frontier Method for Investigating Pancreatic-Related Diseases
    Yuxiang Liu, Nianshuang Li, Yin Zhu · 2023 · International Journal of Molecular Sciences
53. Engineering Heterogeneous Tumor Models for Biomedical Applications
    Zhuhao Wu, Danqing Huang, Jinglin Wang, Yuanjin Zhao, Weijian Sun, Xian Shen · 2023 · Advanced Science
54. The use of patient-derived xenografts and patient-derived organoids in the search for new therapeutic regimens for pancreatic carcinoma. A review
    Emin Gayibov, Tomas Sychra, Alžběta Spálenková, Pavel Souček, Martin Oliverius · 2024 · Biomedicine & Pharmacotherapy
55. Establishment of an organoid bank of biliary tract and pancreatic cancers and its application for personalized therapy and future treatment
    Yoshimasa Saito · 2019 · Journal of Gastroenterology and Hepatology
56. BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
    Louise Walsh, Kathryn E. Haley, Bruce Moran, Brian Mooney, Finbarr Tarrant, Stephen F. Madden, Alessandra Di Grande, Yue Fan, Sudipto Das, Oscar M. Rueda et al. · 2019 · Clinical Cancer Research
57. Impact of Endoscopic Ultrasound-Guided Tissue Acquisition on Decision-Making in Precision Medicine for Pancreatic Cancer: Beyond Diagnosis
    Hiroshi Imaoka, Mitsuhito Sasaki, Yusuke Hashimoto, Kazuo Watanabe, Shoichi Miyazawa, Taro Shibuki, Shuichi Mitsunaga, Masafumi Ikeda · 2021 · Diagnostics
58. Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma Patients
    Alice Usai, Gregorio Di Franco, Margherita Piccardi, Perla Cateni, Luca Emanuele Pollina, Caterina Vivaldi, Enrico Vasile, Niccola Funel, Matteo Palmeri, Luciana Dente et al. · 2021 · Cancers
59. Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer
    Iovanna, Juan · 2021 · Translational Oncology
60. SMAD4 and KRAS Status Shapes Cancer Cell–Stromal Cross-Talk and Therapeutic Response in Pancreatic Cancer
    Eloise G. Lloyd, Muntadher Jihad, Judhell S. Manansala, Wenlong Li, Priscilla S.W. Cheng, Sara Pinto Teles, Gianluca Mucciolo, Joaquín Araos Henríquez, Sally Ashworth, Weike Luo et al. · 2025 · Cancer Research
61. Pancreatic organoids as cancer avatars for true personalized medicine
    Johann Gout, Menar Ekizce, Élodie Roger, Alexander Kleger · 2025 · Advanced Drug Delivery Reviews
62. Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies
    Taymin du Toit‐Thompson, Lionel Yi Wen Leck, Josef Gillson, Nick Pavlakis, Anthony James Gill, Jaswinder Singh Samra, Anubhav Mittal, Sumit Sahni · 2025 · Advanced Drug Delivery Reviews
63. Cancer stem cells in personalized therapy: mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities
    Ling Yin, Shoubing Zhou, Hongliang Zhang, Yuhua Shang, Songquan Wu, Tengchuan Jin · 2025 · Frontiers in Cell and Developmental Biology
64. Patient-derived xenograft models of BRCA-associated pancreatic cancers
    Talia Golan, Dikla Atias, Chani Stossel, Maria Raitses‐Gurevich · 2021 · Advanced Drug Delivery Reviews
65. 9-ING-41, a Small Molecule Inhibitor of GSK-3β, Potentiates the Effects of Chemotherapy on Colorectal Cancer Cells
    Andrey A. Poloznikov, Sergey V. Nikulin, Л. В. Болотина, А. А. Качмазов, M. P. Raigorodskaya, Anna V. Kudryavtseva, Ildar R. Bakhtogarimov, Sergey Rodin, Irina N. Gaisina, Maxim Anatol'evich Topchiy et al. · 2021 · Frontiers in Pharmacology
66. An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies
    Marie C. Hasselluhn, Denise Schlösser, Lennart Versemann, G. Schmídt, Maria Ulisse, Joana Oschwald, Zhe Zhang, Feda H. Hamdan, Harry Xiao, Waltraut Kopp et al. · 2023 · Gastroenterology
67. Addressing Key Questions in Organoid Models: Who, Where, How, and Why?
    María Gómez‐Álvarez, Marcos Agustina‐Hernández, Emilio Francés‐Herrero, Adolfo Rodríguez‐Eguren, Clara Bueno-Fernández, Irene Cervelló · 2023 · International Journal of Molecular Sciences
68. Organoids in ovarian cancer: a platform for disease modeling, precision medicine, and drug assessment
    Haiyao Hu, Chongen Sun, Jingyao Chen, Zhengyu Li · 2024 · Journal of Cancer Research and Clinical Oncology
69. Organoid-Derived Epithelial Monolayer: A Clinically Relevant In Vitro Model for Intestinal Barrier Function
    Wies T. M. van Dooremalen, Merel Derksen, Jamie Lee Roos, Celia Higuera Barón, Carla S. Veríssimo, Robert G.J. Vries, Sylvia F. Boj, Farzin Pourfarzad · 2021 · Journal of Visualized Experiments
70. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold
    Lifeng Hu, Xue Yang, Huanrong Lan, Xingliang Fang, Xiaoyi Chen, Ketao Jin · 2021 · Experimental Cell Research
71. Screening Splice-Switching Antisense Oligonucleotides in Pancreas-Cancer Organoids
    Wan, Ledong, Kral, Alexander J., Voss, Dillon, Schäfer, Balázs, Sudheendran, Kavitha, Danielsen, Mathias, Caruthers, Marvin H., Krainer, Adrian R. · 2024 · Nucleic Acid Therapeutics
72. A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial
    Francesca Sarno, Jair Antonio Tenorio, Sofia Perea, Laura Medina, Roberto Pazo-Cid, Ignacio Juez Martel, Rocio García‐Carbonero, Jaime Feliú, Carmen Guillén‐Ponce, Pedro Pablo Lopez-Casas et al. · 2024 · Clinical Cancer Research
73. Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology
    Clémence Deligne, Arthur Tourbez, Flavie Bénard, Swann Meyer, Alexis Curt, Matteo Gianesello, Maud Hamadou, Léna Clavier, Claire Coquet, Charlotte Bocquet et al. · 2025 · Neuro-Oncology
74. Establishing 3D organoid models from patient-derived conditionally reprogrammed cells to bridge preclinical and clinical insights in pancreatic cancer
    Jin Su Kim, Chan Hee Park, Eun‐Young Kim, Hee Seung Lee, Jin-Young Lee, Jeehoon Kim, Eun Hee Kam, Sanghee Nam, Moon Jae Chung, Jeong Youp Park et al. · 2025 · Molecular Cancer
75. Epigenetic suppression of Nrf2–Slc40a1 axis induces ferroptosis and enhances immunotherapy in pancreatic cancer
    Yixuan Zhang, Ranran Yu, Qi Li, Shiyi Song, Yao Shi Fu, Xinjie Shen, Tianqi Xu, Yin Zhang, Jiawei Liang, Ziying Zhang et al. · 2025 · Journal for ImmunoTherapy of Cancer
76. Organoid research: new concepts and new technologies
    Jin Zhang, Yuezhou Wu, Tianzhuo Shen, Yingrui Mao, Hongjing Dou, Yi Lin, Zhen Geng, Zhanghua Li, Jiacan Su · 2026 · Burns & Trauma
77. Pharmacokinetics and pharmacodynamics of new drugs for pancreatic cancer
    Ryan Sugarman, Rajvi Patel, Sandhya Sharma, Dennis Plenker, David Arthur Tuveson, M. W. Saif · 2019 · Expert Opinion on Drug Metabolism & Toxicology
78. The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids
    Ronnie Ren Jie Low, Wei‐Wen Lim, Paul M. Nguyen, Belinda Lee, Michael Christie, Antony Wilks Burgess, Peter Gibbs, Sean Michael Grimmond, Frédéric Hollande, Tracy L. Putoczki · 2021 · Cancers
79. Organoids as research models for hepatocellular carcinoma
    Justin HY. Yu, Stephanie Ma · 2021 · Experimental Cell Research
80. 3D microgels to quantify tumor cell properties and therapy response dynamics
    Nila C. Wu, Jose L. Cadavid, Xinzhu Tan, Simon Latour, Stefano Scaini, Priya Makhijani, Tracy L. McGaha, Laurie Ailles, Alison P. McGuigan · 2022 · Biomaterials
81. Development of Human Pituitary Neuroendocrine Tumor Organoids to Facilitate Effective Targeted Treatments of Cushing’s Disease
    Jayati L. Chakrabarti, Ritu Pandey, Jared M. Churko, Jennifer Mary Eschbacher, Saptarshi Mallick, Yuliang Chen, Beth Hermes, Palash Mallick, Ben N. Stansfield, Kelvin W. Pond et al. · 2022 · Cells
82. Long-term organoid culture of a small intestinal neuroendocrine tumor
    Sabrina L. D’Agosto, Elena Fiorini, Francesco Pezzini, Pietro Delfino, Michele Simbolo, Caterina Vicentini, Silvia Andreani, Paola Capelli, Borislav Chavdarov Rusev, Rita Teresa Lawlor et al. · 2023 · Frontiers in Endocrinology
83. Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma
    Xiao-chang Fang, Lin Shu, TianLiang Chen, XiaoLe Zhao, LiuCui Yang, Tingting Dou, Lijie Yang, Xuanfei Li, Maohui Feng · 2024 · Molecular Cancer
84. Interaction between MED12 and ΔNp63 activates basal identity in pancreatic ductal adenocarcinoma
    Diogo Maia-Silva, Patrick J. Cunniff, Allison C. Schier, Damianos S. Skopelitis, Marygrace C. Trousdell, Philip Moresco, Yuan Gao, Vahag Kechejian, Xue‐Yan He, Yunus Sahin et al. · 2024 · Nature Genetics
85. Non‐Invasive Quality Control of Organoid Cultures Using Mesofluidic CSTR Bioreactors and High‐Content Imaging
    Seleipiri Charles, Emily Jackson, Gongchen Sun, Ying Zhou, Benjamin Siciliano, Weibo Niu, Haejun Han, Arina A. Nikitina, Melissa Lambeth Kemp, Zhexing Wen et al. · 2024 · Advanced Materials Technologies
86. Hepatocellular-Carcinoma-Derived Organoids: Innovation in Cancer Research
    Carlo Airola, Maria Pallozzi, Eleonora Cesari, Lucia Cerrito, Leonardo Stella, Claudio Sette, Felice Giuliante, Antonio Gasbarrini, Francesca Romana Ponziani · 2024 · Cells
87. Advances in the application of colorectal cancer organoids in precision medicine
    Yanan Zhang, Ruoyu Meng, Dan Sha, Huiquan Gao, Shengxi Wang, Jun Zhou, Xiaoshan Wang, Fuxia Li, Xinyu Li, Wei Song · 2024 · Frontiers in Oncology
88. Preclinical Modelling of PDA: Is Organoid the New Black?
    Sabrina L. D’Agosto, Silvia Andreani, Aldo Scarpa, Vincenzo Corbo · 2019 · International Journal of Molecular Sciences
89. Organotypic Modeling of the Tumor Landscape
    Maria M. Haykal, Clara Nahmias, Christine Varon, Océane C. B. Martin · 2020 · Frontiers in Cell and Developmental Biology
90. Organoid Models for Cancer Research—From Bed to Bench Side and Back
    Carolin Kastner, Anne Hendricks, Hanna Deinlein, Mohammed K. Hankir, Christoph‐Thomas Germer, Stefanie Schmidt, Armin Wiegering · 2021 · Cancers
91. An Engineered Paper‐Based 3D Coculture Model of Pancreatic Cancer to Study the Impact of Tissue Architecture and Microenvironmental Gradients on Cell Phenotype
    Jose L. Cadavid, Simon Latour, Ferris Nowlan, Ileana L. Co, Natalie Landon‐Brace, Bradly G. Wouters, Barbara T. Grünwald, Mark Nitz, Hartland Warren Jackson, Alison P. McGuigan · 2022 · Advanced Healthcare Materials
92. Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2–Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates
    Daniel A. King, Amber Rae Smith, Gino Pineda, Michitaka Nakano, Flavia Michelini, Simon Peter Goedegebuure, Sheeno P. Thyparambil, Wei‐Li Liao, Aaron K. McCormick, Jihang Ju et al. · 2023 · JCO Precision Oncology
93. 3D Models of Sarcomas: The Next-generation Tool for Personalized Medicine
    Ruiling Xu, Ruiqi Chen, Chao Tu, X.Y. Gong, Zhongyue Liu, Lin Mei, Xiaolei Ren, Zhihong Li · 2023 · Phenomics
94. Establishment of a patient-specific avatar organoid model derived from EUS-guided fine-needle biopsy for timely clinical application in pancreatic ductal adenocarcinoma (with video)
    Hye Min Kim, Jinho Jang, Jin Ho Choi, Joo Hye Song, Su Hyun Lee, Ji‐Ho Park, Si Kyong Ryoo, Eun Mi Lee, Hyoung‐oh Jeong, Seunghoon Kim et al. · 2024 · Gastrointestinal Endoscopy
95. KRASG 12 C ‐inhibitor‐based combination therapies for pancreatic cancer: insights from drug screening
    Constanza Tapia Contreras, Jonas Dominik Falke, Dana‐Magdalena Seifert, Carolin Schneider, Lukas Krauß, Xin Fang, Denise Müller, Engin Demirdizen, Melanie Spitzner, Tiago De Oliveira et al. · 2024 · Molecular Oncology
96. Effects of neoadjuvant FOLFIRINOX and gemcitabine-based chemotherapy on cancer cell survival and death in patients with pancreatic ductal adenocarcinoma
    Lihua Xie, Leizhou Xia, Ulla Klaiber, Milena Sachsenmaier, Ulf Hinz, Frank Bergmann, Oliver Strobel, Markus Wolfgang Büchler, John P. Neoptolemos, Franco Fortunato et al. · 2019 · Oncotarget
97. Adjuvant and neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma
    Carl-Stephan Leonhardt, Benno Traub, Thilo Hackert, Ulla Klaiber, Oliver Strobel, Markus Wolfgang Büchler, John P. Neoptolemos · 2020 · Journal of Pancreatology
98. Deletion of Histone Methyltransferase G9a Suppresses Mutant Kras-driven Pancreatic Carcinogenesis
    Hiroyuki Kato, K. Tateishi, H. Fujiwara, Hideaki Ijichi, Keisuke Yamamoto, Takuma Nakatsuka, Miwako Kakiuchi, M. Sano, Yotaro Kudo, Y. Hayakawa et al. · 2020 · Cancer Genomics & Proteomics
99. Operationalizing the Use of Biofabricated Tissue Models as Preclinical Screening Platforms for Drug Discovery and Development
    Olive Jung, Min Jae Song, Marc Ferrer · 2021 · SLAS DISCOVERY
100. Identification of GPC3 mutation and upregulation in a multidrug resistant osteosarcoma and its spheroids as therapeutic target
     Jun‐Hua Nie, Tao Yang, Hong Li, Hai‐Shan Ye, Guo-Qing Zhong, Tingting Li, Chi Zhang, Wenhan Huang, Jin Xiao, Zhi Li et al. · 2021 · Journal of bone oncology